Mr. Petrie was a member of the trial team that represented Ravgen against Laboratory Corporation of America Holdings (“LabCorp”) in a patent infringement jury trial concerning non-invasive prenatal testing. The team achieved a complete victory that resulted in a judgment of over $272M against LabCorp for its willful infringement. Mr. Petrie’s responsibilities at trial included cross-examining one of LabCorp’s expert witnesses and arguing the evidentiary objections that led to LabCorp abandoning its invalidity defense midtrial.
Prior to the LabCorp trial, Mr. Petrie represented ViiV Healthcare and Shionogi in their case against Gilead. The case involved the HIV drugs dolutegravir and bictegravir. Mr. Petrie was involved in the case from drafting the complaint through trial preparations. Shortly before trial was set to begin, the case settled for over $1.25B plus royalties.
Mr. Petrie was also a member of the trial team defending client Cisco against antitrust claims brought by competitor Arista Networks. On the morning of opening statements, Arista Networks agreed to pay Cisco $400M to settle pending disputes between the parties.
Prior to joining Desmarais LLP, Mr. Petrie spent a summer working at a New York-based patent prosecution firm. During law school, he was a member of Cardozo’s Arts & Entertainment Law Journal and spent a semester working in Cardozo’s Tech Startup Clinic providing pro bono legal services to startup companies. Prior to joining law school, Mr. Petrie completed a Master’s degree in Applied Science (chemical engineering), researching conductive polymer nanocomposites.
Prior Experience
- Summer Associate, Desmarais LLP, New York, New York, 2015
- Summer Associate/Legal Intern, Fay Kaplun & Marcin LLP, New York, New York, 2014